sodium thiosulfate has been researched along with Cancer of Ovary in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (53.85) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, H; Cristea, MC; Dellinger, TH; Eng, M; Hakim, A; Han, ES; Kebria, M; Lee, B; Lee, S; Liang, WS; Lin, JF; Lin, WC; Paz, BI; Raoof, M; Rodriguez-Rodriguez, L; Ruel, N; Santiago, NL; Senguttuvan, RN; Stewart, DB; Tinsley, R; Wakabayashi, MT; Wang, EW; Wu, X | 2 |
| Ezono, Y; Hatae, M; Hokanishi, H; Igyuin, H; Terahara, M; Tezuka, H; Ushiki, N | 1 |
| Howell, SB; Olshen, RA; Pfeifle, CE; Wung, WE | 1 |
| Boonstra, H; de Jong, RS; de Vries, EG; Mulder, NH; Sleijfer, DT; van der Graaf, WT; van der Zee, AG; Willemse, PH | 1 |
| Lin, JY; Scheim, DE | 1 |
| Dalesio, O; George, M; Guastalla, JP; Nooij, M; Renard, J; Scotto, V; ten Bokkel Huinnink, WW; Vermorken, JB; Wils, JA | 1 |
| Malmström, H; Rasmussen, S; Simonsen, E | 1 |
| Burger, CW; Hoekman, K; van Rijswijk, RE; Verheijen, RH; Vermorken, JB | 1 |
| Andoh, I; Fujimaru, J; Harada, M; Hirabayashi, K; Iguchi, T; Matsushiro, N; Satoh, M; Shima, Y; Takizawa, K; Yokoo, I | 1 |
| Braly, P; Howell, SB; Kim, S; Kirmani, S; McClay, EF; Plaxe, S | 1 |
| Abe, R; Akiyoshi, T; Baba, T | 1 |
| Goel, R; Horton, MC; Howell, SB; Kim, S; Kirmani, S; Lucas, WE; McVey, L; Morris, J; Weiss, RJ; Zimm, S | 1 |
| Fujimaru, J; Harada, M; Iguchi, T; Ozaki, I; Sato, M; Shima, Y; Takeda, Y; Takizawa, K; Yokoo, I | 1 |
| Bugat, R; Canal, P; Chatelut, E; Chevreau, C; de Forni, M; Houin, G; Johnson, NP | 1 |
| Iguchi, T; Ino, Y; Isono, T; Sato, M; Takeda, Y; Takizawa, K | 1 |
| Beppu, K; Ibaraki, T; Itani, Y; Katoh, Y; Kiyozuka, Y; Maruyama, M; Ninomiya, Y; Noda, T; Okamura, Y; Oku, M | 1 |
| Kamitani, N; Mori, T; Tateyama, I; Tominaga, T | 1 |
| Mano, T; Miyake, T; Nakamura, Y; Saito, T; Takeshima, N; Tomimatsu, T | 1 |
| Hatae, M | 1 |
| Hamai, J; Kato, T; Kobayashi, H; Miyahara, K; Miyoshi, T; Nishimura, H; Tomoo, Y; Yakushiji, M; Yamada, T | 1 |
| Cleary, S; Howell, SB; Markman, M | 2 |
| Howell, SB; Lucas, WE; Markman, M | 1 |
| Aartsen, E; Dubbelman, R; Franklin, H; McVie, JG; ten Bokkel Huinink, WW | 1 |
| Ozols, R | 1 |
1 review(s) available for sodium thiosulfate and Cancer of Ovary
| Article | Year |
|---|---|
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Cisplatin; Etoposide; Female; Humans; Infusions, Parenteral; Ovarian Neoplasms; Survival Rate; Thiosulfates | 1991 |
7 trial(s) available for sodium thiosulfate and Cancer of Ovary
| Article | Year |
|---|---|
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cisplatin; Combined Modality Therapy; Cytoreduction Surgical Procedures; Female; Humans; Hyperthermia, Induced; Hyperthermic Intraperitoneal Chemotherapy; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies | 2023 |
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.
Topics: Administration, Topical; Adult; Aged; Antioxidants; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Cavity; Survival Rate; Thiosulfates | 1995 |
Glucose effects in an ovarian cancer protocol of exceptional activity.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cytarabine; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Glucose; Humans; Ifosfamide; Infusions, Parenteral; Injections, Intravenous; Middle Aged; Models, Biological; Neoplasm Staging; Ovarian Neoplasms; Reoperation; Thiosulfates | 1993 |
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Grou
Topics: Aged; Catheterization, Peripheral; Cisplatin; Female; Humans; Infusions, Parenteral; Kidney Diseases; Leukopenia; Middle Aged; Ovarian Neoplasms; Thiosulfates | 1994 |
Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Injections, Intraperitoneal; Kidney; Middle Aged; Ovarian Neoplasms; Survival Rate; Thiosulfates | 1993 |
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Survival Analysis; Thiosulfates; Treatment Outcome | 1997 |
[The clinical and pharmacokinetic evaluation of two-route chemotherapy with cisplatin and sodium thiosulfate in combination with angiotensin II].
Topics: Angiotensin II; Blood Pressure; Cisplatin; Drug Therapy, Combination; Female; Humans; Ovarian Neoplasms; Thiosulfates; Vasoconstriction | 1992 |
18 other study(ies) available for sodium thiosulfate and Cancer of Ovary
| Article | Year |
|---|---|
ASO Visual Abstract: Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer.
Topics: Cisplatin; Cytoreduction Surgical Procedures; Female; Humans; Hyperthermia, Induced; Hyperthermic Intraperitoneal Chemotherapy; Ovarian Neoplasms; Thiosulfates | 2024 |
[Intraperitoneal and intrapleural two channel chemotherapy by cisplatinum (DDP) and sodium thiosulfate for the treatment of ovarian cancer].
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Cisplatin; Cystadenocarcinoma; Drug Therapy, Combination; Endometriosis; Female; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Pleura; Thiosulfates | 1984 |
Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
Topics: Adult; Cell Division; Cell Line; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Humans; Kinetics; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Dialysis; Thiosulfates | 1983 |
'Two-route chemotherapy' using cisplatin and its neutralizing agent, sodium thiosulfate, for intraperitoneal cancer.
Topics: Adult; Aged; Animals; Antidotes; Breast Neoplasms; Cisplatin; Colonic Neoplasms; Dogs; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Thiosulfates; Time Factors | 1990 |
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Infusions, Parenteral; Ovarian Neoplasms; Remission Induction; Survival Analysis; Thiosulfates; Time Factors | 1990 |
[The hypertensive effect induced with angiotensin II and the physiological and pharmacokinetic aspects of two-route chemotherapy using CDDP and STS].
Topics: Angiotensin II; Blood Pressure; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Ovarian Neoplasms; Thiosulfates | 1990 |
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate.
Topics: Adenocarcinoma; Antidotes; Cisplatin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infusion Pumps; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Thiosulfates | 1989 |
[The pharmacokinetics and clinical toxicities following intraperitoneal infusion of cis-diamminedichloroplatinum (II) with simultaneous sodium thiosulfate rescue in patients with ovarian cancer].
Topics: Antidotes; Cisplatin; Female; Humans; Ovarian Neoplasms; Thiosulfates | 1988 |
[A case report of advanced ovarian cancer with chronic renal dysfunction treated by CDDP i.p].
Topics: Cisplatin; Drug Administration Schedule; Female; Humans; Injections; Kidney Failure, Chronic; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Thiosulfates | 1988 |
[Selective intra-arterial administration of CDDP in a malignant ovarian tumor with peculiar ultrastructural findings].
Topics: Adult; Cisplatin; Cystadenocarcinoma; Female; Humans; Infusions, Intra-Arterial; Ovarian Neoplasms; Ovary; Thiosulfates | 1988 |
[Treatment of gynecological cancer with cis-platinum].
Topics: Adenocarcinoma; Cisplatin; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Reoperation; Thiosulfates; Uterine Neoplasms | 1987 |
[Pharmacokinetics of cisplatinum (CDDP) and sodium thiosulphate (STS) of intraperitoneal two channel chemotherapy (ip TCC) in man and mongrel dogs].
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dogs; Female; Humans; Injections, Intraperitoneal; Kinetics; Middle Aged; Ovarian Neoplasms; Thiosulfates | 1986 |
[An experimental study of cisplatin and it's antidote, sodium thiosulfate, in ovarian pseudomyxoma implanted into nude mice abdominal cavity].
Topics: Animals; Antidotes; Body Weight; Cisplatin; Cystadenoma; Female; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Peritoneal Cavity; Thiosulfates | 1986 |
Hypomagnesemia following high-dose intracavitary cisplatin with systemically administered sodium thiosulfate.
Topics: Adult; Aged; Carcinoma; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Magnesium; Male; Mesothelioma; Middle Aged; Ovarian Neoplasms; Retrospective Studies; Thiosulfates | 1986 |
Intraperitoneal chemotherapy for advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Ovarian Neoplasms; Peritoneal Cavity; Thiosulfates | 1985 |
Experimental and clinical results with intraperitoneal cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheterization; Catheters, Indwelling; Cisplatin; Female; Humans; Infusions, Parenteral; Kidney Diseases; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity; Reoperation; Thiosulfates | 1985 |
Intraperitoneal chemotherapy in the management of ovarian cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Cisplatin; Drug Evaluation; Female; Humans; Infusions, Parenteral; Ovarian Neoplasms; Peritoneal Cavity; Thiosulfates | 1985 |
Nephrotoxicity of high-dose intracavitary cisplatin with intravenous thiosulfate protection.
Topics: Acute Kidney Injury; Adult; Aged; Cisplatin; Creatinine; Female; Humans; Injections; Injections, Intraperitoneal; Male; Mesothelioma; Middle Aged; Ovarian Neoplasms; Pleura; Thiosulfates | 1985 |